This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medtronic's Acquisition Isn't Just About Lowering Its Tax Bill

Interestingly, according to Omar Ishrak, Medtronic's CEO, the company's relocation to Ireland is not going to cause any meaningful reduction in Medtronic's tax rate.

This is because Medtronic has been successfully maintaining a low corporate tax rate by keeping its foreign operations outside of the U.S. The company has also taken advantage of the research and development tax credits. As a result, in the previous fiscal year, the company's effective tax rate was 18.4%.

Following the acquisition, Medtronic will significantly grow in size. Medtronic had more than 46,000 employees and earned annual revenue of $17 billion in its previous fiscal year. The new company, however, will have nearly 87,000 employees and will earn combined revenue of $27 billion, of which nearly 48% will come from outside the U.S.

The bigger Medtronic will have a large portfolio of products for its hospital customers. The company will become a one-stop solution for its clients. Consequently, the new company might post better growth rates than Medtronic or Covidien. The former has struggled with revenue growth in the low-single digits while the latter's sales in 2013 were nearly the same as they were five years ago.

The bigger company, with operations in 150 countries, will be in a better position to compete with the industry leader Johnson & Johnson (JNJ).

The deal will also result in annual pre-tax cost synergies of at least $850 million by 2018. Medtronic has not identified the revenue synergies the deal might create, albeit the details are still coming in. 

At the time of publication, the author held no positions in any of the stocks mentioned.

This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.

>>Cramer: A 'Who's Who' of Tax-Domicile Targets

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MDT $74.46 0.00%
AAPL $94.02 0.00%
FB $104.07 0.00%
GOOG $683.57 0.00%
TSLA $162.60 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs